Literature DB >> 7565758

Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter.

W Zhang1, J Zhang, M Kornuc, K Kwan, R Frank, S D Nimer.   

Abstract

To isolate transcription factors important in the regulation of the human interleukin-3 (IL-3) gene, we screened a lambda gt11 cDNA library, constructed from phytohemagglutinin-stimulated human T-cell RNA, with a probe containing regulatory sequences in the upstream region of the IL-3 gene (located from bp -165 to -128 and referred to as the DNase I footprint A region). We isolated a 0.96-kb cDNA that encoded a basic amino acid domain and a leucine zipper domain and used the "rapid amplification and cloning of 3' ends" technique to isolate the 3' half of the cDNA clone, generating a 1.9-kb full-length cDNA clone. Using in vitro-translated protein, which we call NF-IL3A, we defined the IL-3 promoter sequences bound by NF-IL3A in DNase I footprinting assays as TAATTACGTCTG and, using gel shift assays, defined ATTACG as the minimal sequence required for binding of NF-IL3A in vitro. Proteins that bind to the NF-IL3A binding site are found in both unstimulated and stimulated T-cell lines in similar amounts, although the level of NF-IL3A mRNA increases after T-cell activation in several mature T-cell lines. The NF-IL3A protein is nearly identical to a recently identified transcriptional repressor protein, E4BP4, and NF-IL3A binds specifically to regulatory sequences in both the adenovirus E4 promoter and the human gamma interferon promoter. Cotransfection experiments demonstrate that introduction of an expression vector containing the NF-IL3A cDNA into resting T cells transactivates IL-3 promoter-chloramphenicol acetyltransferase gene plasmids that contain the A region; this effect requires the presence of an intact NF-IL3A binding site. One or more copies of the A region also confer NF-IL3A responsiveness on a heterologous promoter in T cells. NF-IL3A appears to play an important role in the expression of IL-3 by T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565758      PMCID: PMC230857          DOI: 10.1128/MCB.15.11.6055

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

Review 1.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Authors:  P J Mitchell; R Tjian
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

Review 2.  Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.

Authors:  D Bohmann; T J Bos; A Admon; T Nishimura; P K Vogt; R Tjian
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

3.  Contingent genetic regulatory events in T lymphocyte activation.

Authors:  G R Crabtree
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

4.  Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores.

Authors:  M Plaut; J H Pierce; C J Watson; J Hanley-Hyde; R P Nordan; W E Paul
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA.

Authors:  H Singh; J H LeBowitz; A S Baldwin; P A Sharp
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

7.  A simple phase-extraction assay for chloramphenicol acyltransferase activity.

Authors:  B Seed; J Y Sheen
Journal:  Gene       Date:  1988-07-30       Impact factor: 3.688

8.  Regulation of interleukin 3 gene induction in normal human T cells.

Authors:  S C Guba; G Stella; L A Turka; C H June; C B Thompson; S G Emerson
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

9.  Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines.

Authors:  C M Niemeyer; C A Sieff; B Mathey-Prevot; J Z Wimperis; B E Bierer; S C Clark; D G Nathan
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

10.  Production of hematopoietic colony-stimulating factors by human natural killer cells.

Authors:  M C Cuturi; I Anegón; F Sherman; R Loudon; S C Clark; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

View more
  44 in total

1.  Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4.

Authors:  C K Lai; L P Ting
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  The vrille gene of Drosophila is a maternal enhancer of decapentaplegic and encodes a new member of the bZIP family of transcription factors.

Authors:  H George; R Terracol
Journal:  Genetics       Date:  1997-08       Impact factor: 4.562

3.  NFIL3/E4BP4 controls type 2 T helper cell cytokine expression.

Authors:  Masaki Kashiwada; Suzanne L Cassel; John D Colgan; Paul B Rothman
Journal:  EMBO J       Date:  2011-04-15       Impact factor: 11.598

4.  Cell transformation mediated by homodimeric E2A-HLF transcription factors.

Authors:  T Inukai; T Inaba; T Yoshihara; A T Look
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 5.  Probing lymphocyte biology by genomic-scale gene expression analysis.

Authors:  A Alizadeh; M Eisen; D Botstein; P O Brown; L M Staudt
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

6.  E4BP4 is a cardiac survival factor and essential for embryonic heart development.

Authors:  Yi-Jiun Weng; Dennis Jine-Yuan Hsieh; Wei-Wen Kuo; Tung-Yuan Lai; Hsi-Hsien Hsu; Chang-Hai Tsai; Fuu-Jen Tsai; Ding-Yu Lin; James A Lin; Chih-Yang Huang; Kwong-Chung Tung
Journal:  Mol Cell Biochem       Date:  2010-02-26       Impact factor: 3.396

7.  A distal enhancer in Il12b is the target of transcriptional repression by the STAT3 pathway and requires the basic leucine zipper (B-ZIP) protein NFIL3.

Authors:  Amber M Smith; Joseph E Qualls; Kevin O'Brien; Liza Balouzian; Peter F Johnson; Stacey Schultz-Cherry; Stephen T Smale; Peter J Murray
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

8.  Neuroprotective role of the basic leucine zipper transcription factor NFIL3 in models of amyotrophic lateral sclerosis.

Authors:  So-ichi Tamai; Keisuke Imaizumi; Nobuhiro Kurabayashi; Minh Dang Nguyen; Takaya Abe; Masatoshi Inoue; Yoshitaka Fukada; Kamon Sanada
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

9.  IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching.

Authors:  Masaki Kashiwada; Deborah M Levy; Lisa McKeag; Keri Murray; Andreas J Schröder; Stephen M Canfield; Geri Traver; Paul B Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo.

Authors:  Shintaro Kamizono; Gordon S Duncan; Markus G Seidel; Akira Morimoto; Koichi Hamada; Gerard Grosveld; Koichi Akashi; Evan F Lind; Jillian P Haight; Pamela S Ohashi; A Thomas Look; Tak W Mak
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.